- Home
- APLT vs ADV Comparison
APLT vs ADV Comparison
Compare APLT & ADV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APLT | ADV |
|---|---|---|
| Founded | 2016 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.0M | 293.0M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | APLT | ADV |
|---|---|---|
| Price | $0.10 | $0.84 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $1.25 | ★ $2.00 |
| AVG Volume (30 Days) | ★ 10.8M | 1.1M |
| Earning Date | 11-13-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,000,000.00 | ★ $3,502,796,000.00 |
| Revenue This Year | $124.18 | N/A |
| Revenue Next Year | $66.67 | $0.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.09 | $0.80 |
| 52 Week High | $1.50 | $2.98 |
Technical Indicators
Market Signals| Indicator | APLT | ADV |
|---|---|---|
| Relative Strength Index (RSI) | 26.55 | 38.38 |
| Support Level | $0.09 | $0.84 |
| Resistance Level | $0.12 | $0.92 |
| Average True Range (ATR) | 0.01 | 0.07 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 8.79 | 21.51 |
Price Performance
Historical ComparisonAbout APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About ADV Advantage Solutions Inc.
Advantage Solutions Inc is a omnichannel retail solutions agency in North America, uniquely positioned at the intersection of consumer-packaged goods (CPG) brands and retailers.